Skip to content

Clinical trials

Completed Non-alcoholic Fatty Liver Disease trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Status: Completed Country / region: Mexico Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20152
20181
20192
20214
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
AB Biotics, SA1
Akero Therapeutics, Inc1
AstraZeneca1
Eli Lilly and Company1
Fundación Clínica Médica Sur1
Galmed Research and Development, Ltd.1
Hospital Juarez de Mexico1
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran1
Universidad Veracruzana1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease13
Fatty Liver3
Liver Cirrhosis3
Obesity3
Liver Diseases2
Diabetes Mellitus1
Fibrosis1
Obesity, Morbid1
Weight Loss1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.